A urine test to diagnose obstructive sleep apnea in children
UroMarker Test Panel for Obstructive Sleep Apnea
['FUNDING_SBIR_2'] · PGXL TECHNOLOGIES, LLC · NIH-10919156
This study is working on a simple urine test to help doctors quickly and easily find out if kids have obstructive sleep apnea, a condition that can affect their sleep and learning, making it easier for families to get the help they need.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PGXL TECHNOLOGIES, LLC (nih funded) |
| Locations | 1 site (LOUISVILLE, UNITED STATES) |
| Trial ID | NIH-10919156 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a non-invasive urine-based test to diagnose obstructive sleep apnea (OSA) in children. OSA can cause serious health issues, including sleep disturbances and cognitive impairments, but current diagnostic methods are often invasive and expensive. The new test aims to provide a quicker and more accessible way to identify OSA, allowing for better monitoring and treatment of affected children. By using a multiplexed immunoassay, the researchers hope to screen a larger population effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who exhibit symptoms of obstructive sleep apnea or are at risk for the condition.
Not a fit: Patients who do not have symptoms of obstructive sleep apnea or are older than 11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of obstructive sleep apnea in children, improving their overall health and quality of life.
How similar studies have performed: While there have been various approaches to diagnosing sleep apnea, this urine-based assay represents a novel method that has not been widely tested in children.
Where this research is happening
LOUISVILLE, UNITED STATES
- PGXL TECHNOLOGIES, LLC — LOUISVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BURNS, CHRISTOPHER THOMAS — PGXL TECHNOLOGIES, LLC
- Study coordinator: BURNS, CHRISTOPHER THOMAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.